Pharmacological and non-pharmacological management of the congenital long QT syndrome: the rationale
about
Jervell and Lange-Nielsen syndrome in a father and daughter from a large highly inbred family: a 16-year follow-up of 59 living members.Cascade screening in families with inherited cardiac diseases driven by cardiologists: feasibility and nationwide outcome in long QT syndrome.Prevention of Pazopanib-Induced Prolonged Cardiac Repolarization and Proarrhythmic EffectsThe voltage-gated channel accessory protein KCNE2: multiple ion channel partners, multiple ways to long QT syndrome.Genetics of congenital and drug-induced long QT syndromes: current evidence and future research perspectives.Prevalence, mutation spectrum, and cardiac phenotype of the Jervell and Lange-Nielsen syndrome in Sweden.
P2860
Pharmacological and non-pharmacological management of the congenital long QT syndrome: the rationale
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Pharmacological and non-pharma ...... ong QT syndrome: the rationale
@ast
Pharmacological and non-pharma ...... ong QT syndrome: the rationale
@en
type
label
Pharmacological and non-pharma ...... ong QT syndrome: the rationale
@ast
Pharmacological and non-pharma ...... ong QT syndrome: the rationale
@en
prefLabel
Pharmacological and non-pharma ...... ong QT syndrome: the rationale
@ast
Pharmacological and non-pharma ...... ong QT syndrome: the rationale
@en
P2860
P1476
Pharmacological and non-pharma ...... ong QT syndrome: the rationale
@en
P2860
P304
P356
10.1016/J.PHARMTHERA.2011.03.001
P577
2011-03-17T00:00:00Z